Jun-Peng Lin1,2,3, Feng-Nian Zhuang1,2,3, Wei-Jie Chen1,2,3

  • 1Department of Thoracic Oncology Surgery, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, No. 420 Fuma Road, Fuzhou, 350001, Fujian Province, China.

PubMed
概括

新辅助化学疗法与免疫疗法 (NACI) 结合显示了与新辅助化学辐射疗法 (NCRT) 相似的生存结果,用于边缘切除的食道状细胞癌. NACI与较少的严重术后并发症有关,这表明它是一种安全有效的选择.